Abstract: At least one processor identifies dependency relationships among libraries in a repository of libraries. Using the dependency relationships among libraries, at least one machine learning model can be created that predicts with a confidence value a dependency between a given library and a target library. An L layer tree-like graph can be created, using the dependency relationships among libraries and an application package. L can be configurable. Versions of the libraries to use can be determined by running the at least one machine learning model for each pair of nodes having a dependency relationship in the L layer tree-like graph, the at least one machine learning model identifying the dependency relationship with a confidence value, where pairs of nodes having largest confidence values are selected as the versions of the libraries to use in the application package.

Abstract: The present disclosure provides a cell configuration determination method and apparatus, and a storage medium. The cell configuration determination method includes: receiving area information of at least one area covered by a cell; receiving cell configuration information corresponding to the area information; and on the basis of a position where a terminal is located, the area information of the at least one area, and the cell configuration information corresponding to the area information, determining a target area where the terminal is located and cell configuration information corresponding to the target area.

Abstract: Disclosed is the use of a combination of an anti-PD-1 antibody and a VEGFR inhibitor in the preparation of a drug for treating cancers.

Abstract: A method and an apparatus for configuration a period for SSB measurement. The method includes: detecting an SSB of a neighboring cell within the period for SSB measurement, in which the period for SSB measurement includes: an SSB measurement timing configuration (SMTC) window and/or a measurement gap; and reporting update indication information based on a detection result of the SSB, in which the update indication information is configured to update a period configuration at a network side, and the period configuration includes indication information for determining the period for SSB measurement.

Abstract: A cell handover method is provided. The method is performed by a terminal and includes determining whether to ignore a handover command of cell handover according to a predicted value of a predicted parameter, in which the predicted parameter comprises a mobility and service characteristic parameter and/or a communication performance characteristic parameter of the terminal after the terminal is handed over to a target cell.

Abstract: A high-throughput 3D printing system for preparing multi-component, small sized samples, includes a raw material supply module, providing a various kinds of metal powders for printing small sized samples; the first mixer module, mixing the metal powders obtained from the raw material supply module to generate the first blended metal powders; the second mixer module, mixing the first mixed metal powders, in order to generate the second blended metal powders for printing small sized samples; the first printing module, printing the secondary blended metal powder into a small-sized sample; a control module, controlling other functional modules of the high-throughput 3D printing system for generating small-size samples.

Abstract: Carbamate and beta-amino acid urea-based scaffolds that have high binding affinity to PSMA are disclosed. These scaffolds can be radiolabeled and used for imaging cells and tumors that express PSMA or for cancer radiotherapy. These compounds also can comprise a fluorescent dye and be used for imaging cells and tumors that express PSMA or for photodynamic therapy.

Abstract: A composition comprising a glycosaminoglycan component, and one or more extracellular matrix components forming a precipitate with the glycosaminoglycan component, wherein the precipitate has a glycosaminoglycan to hydroxyproline ratio from about 1:10 to about 100:1. In particular, it is a GAG-rich composition with controllable and high glycosaminoglycan (GAG) content that mimics the extracellular matrix (ECM) of GAG-rich native tissues. Also provided is a method of making and using the aforesaid composition. Further provided is a method of treating a tissue disorder in a subject using the aforesaid composition. The composition may be used as scaffolds for applications such as microcarriers, 3D culture substrates, swelling agent, volume filling agent, replacement of nucleus pulposus, cartilage, and other GAG-rich tissues.

Abstract: A method for selecting a relay UE, a method for processing information are provided. The method for selecting a relay UE includes selecting, according to load information of candidate UEs, a relay UE from the candidate UEs.

Abstract: The present disclosure relates to a method and apparatus for requesting scheduling sidelink resources, and a storage medium. The method is applied to a terminal device, and includes: sending a sidelink terminal message to a network device, wherein the sidelink terminal message comprises a request initiated by the terminal device for performing sidelink resource scheduling by the terminal device; receiving a response message corresponding to the sidelink terminal message sent by the network device; in response to that the response message is a first response message indicating that the request from the terminal device is approved, obtaining assigned sidelink resource configuration information from the first response message; and performing sidelink resource scheduling for respective terminal devices within a user group including the terminal device based on the assigned sidelink resource configuration information.

Abstract: A method for controlling a sidelink (SL) is performed by a first user equipment (UE) and includes: monitoring an SL channel within a timing duration started by a first timer, wherein the first timer is configured to start timing after an SL transmission.

Abstract: The present invention discloses a combinational therapy for enhancing efficacy of immune checkpoint blockade for tumors with immune suppressive microenvironment. More specifically, this combination therapy involves the treatment of cancer through immune checkpoint inhibitors and CpG-oligodeoxynucleotides.

Abstract: Aspects of the disclosure are directed to a DRX configuration method and an apparatus, a communication device and a storage medium. The method can be applied to a first terminal, and includes determining DRX configuration of a second terminal according to time domain location information used by the second terminal on Sidelink (SL) to sense transmission resources.

Abstract: A method for receiving system information that is applied to a terminal includes: sending a system information request message to a first access network device, the system information request message carrying an identification of a neighbor cell and an identification of a system information block (SIB) X, where X is an integer greater than 1; and receiving other system information (Other SI) broadcasted by a second access network device. The Other SI carries the SIB X. The first access network device is an access network device for a cell where the terminal currently dwells, and the second access network device is an access network device for the neighbor cell.

Abstract: A method for connection establishment is performed by a relay device, and includes: in response to receiving connection-related information from a remote device, determining a reason for performing a connection establishment or a connection resumption with a base station by the relay device according to the connection-related information, wherein the connection-related information is configured to indicate a connection request of the remote device.

Abstract: The present disclosure belongs to the technical field of biomedicine, and specifically relates to a PSMA inhibitor, compound and use thereof. The PSMA inhibitors having a novel core structure provided in the present disclosure has a wide range of potential applications.

Abstract: The embodiments of the present disclosure provide a method for wireless transmission method, which is performed by a terminal. The method includes: determining, according to at least one of a priority of data and a priority of a ranging signal, a transmission operation on an overlapping resource location; wherein a resource location for transmitting the data and a resource location for transmitting the ranging signal overlap at the overlapping resource location.

Abstract: A method for a terminal to acquire measurement information is provided. The method is applied to the terminal, the method includes receiving configuration information for the terminal to acquire measurement information, and the configuration information is used for determining an acquisition period of the measurement information according to movement information of the terminal.

Abstract: A method and an apparatus for determining a target cell of UE, a communication device, and a storage medium, the method for determining a target cell of UE including: determining, based on measured signal quality on a cell, a candidate cell for cell handover or cell reselection; determining, based on a mobility management parameter and a benefit algorithm model, an expected benefit of accessing the candidate cell; and selecting, based on the expected benefit, from the candidate cell a target cell for cell handover or cell reselection.

Abstract: A method for processing data includes: determining a second UE based on logical channel priorities of logical channels corresponding to SL-DRBs and/or SL-SRBs of data to be transmitted; and determining a medium-access-control protocol data unit (MAC PDU) for transmitting to the second UE, in which the MAC PDU includes data to be transmitted in one or more sidelink radio bearers (SL-RBs) determined based on logical channel priorities of logical channels corresponding to SL-RBs of the second UE, and the SL-RBs of the second UE include SL-DRB(s) of the second UE and/or SL-SRB(s) of the second UE.